SHANGHAI, Sept. 30, 2020 /PRNewswire/ -- On September 24, 2020, 111, Inc. ("111" or the
"Company") (NASDAQ: YI), a leading digital healthcare platform
dedicating to digitally connecting patients with drugs and
healthcare services in China,
hosted its 3rd annual China Online Healthcare Summit and
Partnership Conference (the "Healthcare Summit") in Shanghai, China. This year's theme focused on
"The Age of Technology and Healthcare Digitalization".
As technology ushers in a new digital era for healthcare, the
Chinese government has instituted a number of new regulations to
modernize the healthcare industry as well as to encourage the
development of virtual healthcare services. Transformative
healthcare platforms that provide consumers with more efficient and
convenient access to healthcare plays an important role in
addressing the needs of an aging population. These new regulations
including volume-based procurement policies, have created
challenges to the traditional drug commercialization process, and
the Healthcare Summit provided an ideal forum for industry leaders
to gather and discuss these challenges as well as the innovations
poised to tackle these challenges, such as 111's pioneering
omni-channel platform.
The Healthcare Summit attracted approximately 600 guests
globally, including executives from leading pharmaceutical and
healthcare companies, medical experts, government leaders, and
investment institutions. During the conference, 111, Inc. announced
strategic cooperation agreements with Novartis, Bayer Healthcare,
Huluwa Pharmaceutical, Xiangxue Pharmaceutical, Agilent
Technologies Inc., Shanghai Juyin Information Technology Co. Ltd.
and Zoenet (Xiamen) Health Co.
Ltd.
Dr. Gang YU, Co-founder and Executive Chairman of 111, Inc.,
stated that over the next decade, the rapid adaptation of digital
technology in the healthcare industry will propel the sector to
become the largest industry in China, surpassing real estate and the auto
industry.
Junling LIU, Co-founder, Chairman and CEO of 111, Inc., added
that as a digital healthcare platform, 111, Inc. is able to connect
patients with medical and healthcare products and services
organically through digital technologies. "111, Inc. has built an
ecosystem in which we empower pharmaceutical companies,
pharmaceutical distributors, pharmacies, doctors, and insurance
companies through technologies."
About 111, Inc.
111, Inc. (NASDAQ: YI) ("111" or the "Company") is a leading
digital healthcare platform dedicating to digitally connecting
patients with drugs and healthcare services in China. The Company provides millions of
consumers with better access to pharmaceutical products and
healthcare services directly through its online retail pharmacy 1
Drugstore and indirectly through its offline virtual pharmacy
network. The Company also offers online healthcare services through
its internet hospital, 1 Clinic, which provides consumers with
cost-effective and convenient online consultation, electronic
prescription service and patient management service. In addition,
the Company's online wholesale pharmacy, 1 Drug Mall, serves as a
one-stop shop for pharmacies to source a vast selection of
pharmaceutical products. With the largest virtual pharmacy network
in China, 111 enables offline
pharmacies to better serve their customers with cloud-based
services. 111 also provides omni-channel support to its strategic
partners in their drug commercialization effort, with services such
as digital marketing, patient education, data analytics and pricing
monitoring.
For more information on 111, please visit:
http://ir.111.com.cn/.
For more information, please contact:
111, Inc.
Investor Relations
Email: ir@111.com.cn
111, Inc.
Media Relations
Email: press@111.com.cn
Phone: +86-021-2053 6666 (China)
GCM Strategic Communications
IR Counsel
Email: 111.ir@gcm.international
View original
content:http://www.prnewswire.com/news-releases/111-inc-builds-digitally-enabled-omni-channel-drug-commercialization-platform-as-part-of-its-goal-to-provide-full-life-cycle-healthcare-management-solutions-for-patients-301141658.html
SOURCE 111, Inc.